Diamedica Therapeutics Inc (DMAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 9,033 | 8,007 | 8,144 | 8,419 | 6,883 |
| Operating Income | -9,033 | -8,007 | -8,144 | -8,419 | -6,883 |
| Other Income | 419 | 314 | 443 | 528 | 616 |
| Pre-tax Income | -8,614 | -7,693 | -7,701 | -7,891 | -6,267 |
| Income Tax | 6 | 6 | 6 | 9 | 7 |
| Net Income Continuous | -8,620 | -7,699 | -7,707 | -7,900 | -6,274 |
| Net Income | $-8,620 | $-7,699 | $-7,707 | $-7,900 | $-6,274 |
| EPS Basic Total Ops | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 |
| EPS Basic Continuous Ops | -0.17 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Diluted Total Ops | -0.17 | -0.18 | -0.18 | -0.18 | -0.15 |
| EPS Diluted Continuous Ops | -0.17 | -0.18 | -0.18 | -0.19 | -0.15 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.18 | -0.18 | -0.18 | -0.15 |
| EBITDA(a) | $-9,264 | $-8,184 | $-8,394 | $-8,738 | $-7,238 |